These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21863762)

  • 1. [Lymphoid malignancies: progress in diagnosis and treatment. Topics: III. Diagnosis and treatment; 3. Diagnosis, laboratory examination, and treatment for multiple myeloma].
    Miwa A
    Nihon Naika Gakkai Zasshi; 2011 Jul; 100(7):1850-74. PubMed ID: 21863762
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hematologic Malignancies/Pediatric Malignancies. III. Treatment of Relapsed/Refractory Multiple Myeloma].
    Murakami H; Saitoh T; Kasamatsu T
    Gan To Kagaku Ryoho; 2016 May; 43(5):539-44. PubMed ID: 27344682
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lymphoid malignancies: progress in diagnosis and treatment. Topics: III. Diagnosis and treatment: 4. Role of hematopoietic stem cell transplantation in the treatment of lymphoid malignancies].
    Kanda Y
    Nihon Naika Gakkai Zasshi; 2011 Jul; 100(7):1875-84. PubMed ID: 21863763
    [No Abstract]   [Full Text] [Related]  

  • 4. [IgE myeloma. Laboratory typing difficulties].
    Bovone NS; Fuente MC; Gastiazoro AM; Alfonso G; Freitas MJ
    Medicina (B Aires); 2014; 74(6):472-3. PubMed ID: 25555008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory assessment of multiple myeloma.
    Morrison T; Booth RA; Hauff K; Berardi P; Visram A
    Adv Clin Chem; 2019; 89():1-58. PubMed ID: 30797467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Importance of selected laboratory indicators in the differential diagnosis and monitoring of multiple myeloma].
    Maisnar V; Tousková M; Malý J; Krejsek J; Kmonícek M; Kopecký O
    Vnitr Lek; 2002 Apr; 48(4):290-7. PubMed ID: 12061177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple myeloma: a therapeutic enigma.
    Hoogstraten B
    Am J Clin Oncol; 1982 Feb; 5(1):13-9. PubMed ID: 7081135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multiple Myeloma: from Diagnosis to the Up-to-date Treatment. Topics: II. The Diagnosis of Multiple Myeloma].
    Ishida T
    Nihon Naika Gakkai Zasshi; 2016 Jul; 105(7):1209-15. PubMed ID: 30168964
    [No Abstract]   [Full Text] [Related]  

  • 9. The Diagnosis and Treatment of Multiple Myeloma.
    Gerecke C; Fuhrmann S; Strifler S; Schmidt-Hieber M; Einsele H; Knop S
    Dtsch Arztebl Int; 2016 Jul; 113(27-28):470-6. PubMed ID: 27476706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Smoldering myeloma].
    Dolgos J; Patakfalvi A
    Orv Hetil; 1993 Sep; 134(39):2155-7. PubMed ID: 8414460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lymphoid malignancies: progress in diagnosis and treatment. Topics: IV. Prognosis and cooperation between hospitals and community clinics; 1. Prognosis and prognostic factors in lymphoid malignancy].
    Danbara M; Kamata H; Okina S
    Nihon Naika Gakkai Zasshi; 2011 Jul; 100(7):1898-908. PubMed ID: 21863765
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lymphoid malignancies: progress in diagnosis and treatment. Topics: I. Pathogenesis and pathophysiology--recent findings; 3. Etiology and pathogenesis of plasma cell dyscrasia including multiple myeloma].
    Hattori Y
    Nihon Naika Gakkai Zasshi; 2011 Jul; 100(7):1773-80. PubMed ID: 21863752
    [No Abstract]   [Full Text] [Related]  

  • 13. [CME: Multiple Myeloma - a Review].
    Bräutigam M; Biskup E
    Praxis (Bern 1994); 2018 Jul; 107(14):749-754. PubMed ID: 29969971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-laboratory discordance of beta-2 microglobulin results: impact on the validity of the international staging system for multiple myeloma.
    Fedele PL; Choy KW; Doery JC; Grigoriadis G; Shortt J; Lu ZX
    Br J Haematol; 2014 Sep; 166(6):951-3. PubMed ID: 24779958
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasmacytoma of the mastoid bone: solitary and systemic.
    Engelsma RJ; De Bree R; Janssen JJ; Scheeren RA
    J Laryngol Otol; 2000 May; 114(5):378-80. PubMed ID: 10912271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of 20 cases of multiple myeloma].
    Machalski M; Wodniecki J; Jankowska B
    Wiad Lek; 1967 Apr; 20(7):641-6. PubMed ID: 6061233
    [No Abstract]   [Full Text] [Related]  

  • 17. Is it time for preemptive drug treatment of asymptomatic (smoldering) multiple myeloma?
    Fawole A; Abonour R; Stender M; Shatavi S; Gaikazian S; Anderson J; Jaiyesimi I
    Leuk Lymphoma; 2015 Jan; 56(1):34-41. PubMed ID: 24564573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of Myeloma Testing in Clinical Chemistry with Mass Spectrometry.
    Murray DL; Willrich MAV
    J Appl Lab Med; 2019 Nov; 4(3):474-476. PubMed ID: 31659091
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical picture, diagnosis and treatment of myeloma disease].
    Grinenko KG; Eremeev VS; Ostrovskiĭ KG; Strashko LS
    Vrach Delo; 1976 Jul; (7):100-3. PubMed ID: 997439
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunoglobulin D lambda multiple myeloma: a case report].
    Qiao SK; Zhang XJ; Wang FX; Pan L; Yao L; Dong ZR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):643-6. PubMed ID: 17605885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.